Search research articles
Contact Us
Filters
Showing results (1-10 of 424) with videos related to
Page
of 43
Sort By:
Oncotarget
|
October 6, 2017
Mitochondrial markers predict survival and progression in non-small cell lung cancer (NSCLC) patients: Use as companion diagnostics
Federica Sotgia, Michael P Lisanti
Advances in Experimental Medicine and Biology
|
March 14, 2012
Caveolin-1 and breast cancer: a new clinical perspective
Isabelle Mercier, Michael P Lisanti
Aging
|
October 13, 2020
Using the common cold virus as a naturally occurring vaccine to prevent COVID-19: Lessons from Edward Jenner
Federica Sotgia, Michael P Lisanti
Oncotarget
|
October 6, 2017
Mitochondrial biomarkers predict tumor progression and poor overall survival in gastric cancers: Companion diagnostics for personalized medicine
Federica Sotgia, Michael P Lisanti
Oncotarget
|
October 6, 2017
Mitochondrial mRNA transcripts predict overall survival, tumor recurrence and progression in serous ovarian cancer: Companion diagnostics for cancer therapy
Federica Sotgia, Michael P Lisanti
Molecular Interventions
|
March 3, 2004
The biology of caveolae: lessons from caveolin knockout mice and implications for human disease
Robert Hnasko, Michael P Lisanti
Genome Biology
|
March 9, 2004
The caveolin proteins
Terence M Williams, Michael P Lisanti
American Journal of Physiology. Cell Physiology
|
February 5, 2005
Caveolin-1 in oncogenic transformation, cancer, and metastasis
Terence M Williams, Michael P Lisanti
American Journal of Physiology. Heart and Circulatory Physiology
|
January 24, 2006
Defining lipid raft structure and function with proximity imaging
Philippe G Frank, Michael P Lisanti
The American Journal of Pathology
|
March 29, 2012
Translational discoveries, personalized medicine, and living biobanks of the future
Michael P Lisanti, Herbert B Tanowitz
Page
of 43
Search research articles
Search
Showing results (1-10 of 424) with videos related to
Sort By:
Page
of 43
Oncotarget
|
October 6, 2017
Mitochondrial markers predict survival and progression in non-small cell lung cancer (NSCLC) patients: Use as companion diagnostics
Federica Sotgia, Michael P Lisanti
Advances in Experimental Medicine and Biology
|
March 14, 2012
Caveolin-1 and breast cancer: a new clinical perspective
Isabelle Mercier, Michael P Lisanti
Aging
|
October 13, 2020
Using the common cold virus as a naturally occurring vaccine to prevent COVID-19: Lessons from Edward Jenner
Federica Sotgia, Michael P Lisanti
Oncotarget
|
October 6, 2017
Mitochondrial biomarkers predict tumor progression and poor overall survival in gastric cancers: Companion diagnostics for personalized medicine
Federica Sotgia, Michael P Lisanti
Oncotarget
|
October 6, 2017
Mitochondrial mRNA transcripts predict overall survival, tumor recurrence and progression in serous ovarian cancer: Companion diagnostics for cancer therapy
Federica Sotgia, Michael P Lisanti
Molecular Interventions
|
March 3, 2004
The biology of caveolae: lessons from caveolin knockout mice and implications for human disease
Robert Hnasko, Michael P Lisanti
Genome Biology
|
March 9, 2004
The caveolin proteins
Terence M Williams, Michael P Lisanti
American Journal of Physiology. Cell Physiology
|
February 5, 2005
Caveolin-1 in oncogenic transformation, cancer, and metastasis
Terence M Williams, Michael P Lisanti
American Journal of Physiology. Heart and Circulatory Physiology
|
January 24, 2006
Defining lipid raft structure and function with proximity imaging
Philippe G Frank, Michael P Lisanti
The American Journal of Pathology
|
March 29, 2012
Translational discoveries, personalized medicine, and living biobanks of the future
Michael P Lisanti, Herbert B Tanowitz
Page
of 43